Single Blinded First CMC Osteoarthritis Treatment

NCT03196310 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2026-04-08

No results posted yet for this study

Summary

Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.

Conditions

  • Osteoarthritis Thumb

Interventions

DRUG

Platelet Concentrate

Platelet Rich plasma

DRUG

Corticosteroid injection

Kenalog

OTHER

Normal Saline

Control Group - Placebo

Sponsors & Collaborators

  • Kettering Health Network

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03196310 on ClinicalTrials.gov